Clinical Research Directory

Drug Response Profiling (DRP) Registry Zurich for Hematological Malignancies

Sponsor: University Children's Hospital, Zurich

Summary

This study is a prospective, non-randomized feasibility study of drug response profiling (DRP) in pediatric blood cancers. Primary cancer cells are isolated from patients and screened ex vivo at single-cell resolution using automated fluorescence microscopy. Drug sensitivity fingerprints are integrated with genetic annotations to inform the treating physician about personalized treatment options. The study aims to determine the practicability of real-time drug response profiling and its actionability in identifying patient-specific cancer dependencies in refractory disease settings.

Key Details

Conditions

Locations (1)